Premium
Contact dermatitis from topical antiviral drugs
Author(s) -
Holdiness Mack R.
Publication year - 2001
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1034/j.1600-0536.2001.440501.x
Subject(s) - cidofovir , penciclovir , medicine , foscarnet , ganciclovir , dermatology , vidarabine , contact dermatitis , idoxuridine , furocoumarins , allergic contact dermatitis , aciclovir , famciclovir , lamivudine , imiquimod , valaciclovir , nevirapine , pharmacology , immunology , allergy , surgery , human immunodeficiency virus (hiv) , virus , viral disease , chemotherapy , herpesviridae , photochemistry , fludarabine , chemistry , herpes simplex virus , human cytomegalovirus , cyclophosphamide , hepatitis b virus , antiretroviral therapy , viral load
The literature has been reviewed for contact dermatitis from topical antiviral drugs. 15 agents have been identified including acyclovir, imiquimod, podophyllin, podofilox, cidofovir, penciclovir, vidarabine, idoxuridine, trifluridine, tromantadine, lamivudine, interferon intralesional injections and ophthalmic solution, fomivirsen and foscarnet intravitreal injections and ganciclovir intraocular implants. Patch testing has been documented in certain individuals and cross‐sensitization has been observed to contribute significantly to some allergic reactions.